Select a category
Advertisement
Instablog9ja
4 wks
15
A Medical doctor has shocked the nation by listing 20 unhealthy Nigerian foods.
The list included Shawarma, Pizza, Hot Dog, Noodles, Bread, Foreign Rice, Spaghetti, Snacks, Butter, Sardines, Canned Food, Sugars, Soft drinks, Energy drinks, Semo, Ofe akwu (banga soup) Eat but in moderation. The red oil in that soup is to much, Biscuits, Ice cream, Imported fruits and Hydrogenated oils are Poison.
Investopedia
4 wks
13
:max_bytes(150000):strip_icc()/INV_KeithGill_RoaringKitty_GettyImages-2155813221-807b4a7426bd4cd5b1f3b5d0cccc9015.jpg)
Keith Gill, the former financial analyst known online as "Roaring Kitty," is credited for the GameStop stock surge in late 2020, when he posted on YouTube and Reddit his belief that GameStop (GME) shares were undervalued. Gill bought $53,000 worth of GameStop stock in 2019, valued at $48 million at the height of the GameStop surge in January 2021.
Because much of Gill's net worth seems to be tied to his investment in GameStop, it can fluctuate. After stepping back from the public in June 2021, Gill returned in May 2024 with cryptic memes posted to his X account, followed by snapshots of his GameStop portfolio posted to his Reddit account, DeepF---ingValue, or DFV, in June. Shares of GME surged at the time in response to Roaring Kitty's return to social media and renewed interest in meme stocks.
On June 13, 2024, Gill shared a snapshot of his portfolio on Reddit, showing that his holdings included more than 9 million shares in GameStop, worth $262 million, and another $6.3 million in cash. His overall net worth at that time was about $268 million.
During a YouTube livestream on June 7, 2024—his first in three years—Gill shared his E*Trade portfolio on screen and revealed that his GameStop positions were his only investments.
In July 2024, a Securities and Exchange Commission (SEC) filing showed that Gill also owns a 6.6% stake in pet product retailer, Chewy (CHWY). According to the filing, Gill owns 9 million shares of Chewy. Chewy was founded by billionaire Ryan Cohen, GameStop's chief executive officer (CEO). Gill praised Cohen during his livestream in June.
Gill's role in the GameStop phenomenon made it to the big screen in 2023 with Sony Pictures releasing a film called "Dumb Money," depicting Gill's real-life story and journey during the 2020-2021 GameStop craze.
Do you have a news tip for Investopedia reporters? Please email us at [email protected]Read more on Investopedia
Advertisement
Investopedia
4 wks
15
:max_bytes(150000):strip_icc()/focused-scientist-examining-petri-dishes-554996593-af73caf871954a18897c4f8e4e893d29.jpg)
Biohaven (BHVN) shares soared 15% Monday after the biotech firm announced positive results from a study of its experimental treatment for a rare neurological condition.
The company reported data collected over multiple analyses of its drug, troriluzole, showed "a robust and clinically meaningful slowing of disease progression" over a three-year period in patients with spinocerebellar ataxia, or SCA.
Biohaven noted that SCA is a progressively debilitating neurodegenerative disease that affects some 15,000 people in the U.S. and 24,000 in Europe and the U.K., and there is no Food and Drug Administration (FDA)-approved medicine for it.
The research indicated those taking troriluzole had a 50% to 70% slower rate of decline compared with untreated patients, which it explained represented a delay in disease progression of 1.5 years to 2.2 years over the three-year study period.
Biohaven said that it plans to submit a New Drug Application to the FDA in the fourth quarter of this year, and with approval expects to have troriluzole on the market in the U.S. next year.
The news sent shares of Biohaven into positive territory for 2024.
Do you have a news tip for Investopedia reporters? Please email us at [email protected]Read more on Investopedia
Investopedia
4 wks
14
:max_bytes(150000):strip_icc()/GettyImages-2169095535-e0b1ad5cf70a42df9bea997a5b976e20.jpg)
Novo Nordisk's (NVO) U.S.-listed shares lost ground Monday, a day before a Senate hearing on the costs of the company's popular weight-loss drugs Wegovy and Ozempic.
CEO Lars Fruergaard Jorgensen is scheduled to testify Tuesday from the company’s home in Denmark before the Senate Health, Education, Labor, and Pensions Committee.
The committee accused the company of charging "outrageously high prices" for its treatments.
The committee said Americans with Type 2 diabetes pay $969 a month for Ozempic, compared to $155 in Canada, $122 in Denmark, and $59 in Germany. It added that Americans are charged $1,349 a month for Wegovy, more than the $186 in Denmark, $140 in Germany, and $92 in the United Kingdom.
In an interview with last month, Jorgensen defended the company’s pricing, saying that insurance coverage varies from country to country, and that most Americans with health insurance pay $25 a month for Wegovy.
Novo Nordisk shares were down 3.3% at $123.55 in intraday trading Monday, extending Friday's losses after the company reported disappointing results from a study of an experimental weight-loss treatment. Still, they are up about 19% from the start of the year.
Do you have a news tip for Investopedia reporters? Please email us at [email protected]Read more on Investopedia
Investopedia
4 wks
13
:max_bytes(150000):strip_icc()/GettyImages-2172366836-b0d34b184ecd4a959dc1fceaa428ac37.jpg)
U.S. equities were up slightly at midday to start the new week after last week's excitement over the Federal Reserve's 50-basis-point (bps) interest-rate cut sent the Dow Jones Industrial Average to an all-time high. The Dow, S&P 500, and Nasdaq were all in the green.
Tesla (TSLA) shares gained after Goldman Sachs said next month's planned robotaxi reveal could be a catalyst for the stock.
Shares of Palantir Technologies (PLTR) and Erie Indemnity (ERIE) were higher on their first day as members of the S&P 500.
Shares of Newmont (NEM), Freeport-McMoRan (FCX), and other gold miners advanced as the price of the precious metal hit a record high.
General Motors (GM) shares declined after Chief Executive Officer (CEO) Mary Barra reiterated that the automaker would make only electric light-duty vehicles by 2035 even as EV demand slows.
Shares of Ulta Beauty (ULTA) dropped when TD Cowen downgraded the stock, citing lower demand and increasing competition.
American depositary receipts (ADRs) of Novo Nordisk (NVO) slipped ahead of tomorrow's Senate hearing on the drug maker's pricing of its wildly popular Wegovy and Ozempic weight-loss treatments.
Oil prices were lower. The yield on the 10-year Treasury note rose slightly. The U.S. dollar climbed against the euro, but lost ground to the pound and yen. Most major cryptocurrencies traded in positive territory.
Do you have a news tip for Investopedia reporters? Please email us at [email protected]Read more on Investopedia
Advertisement
Instablog9ja
4 wks
11
Actress Kate Henshaw has reacted to reports of a potential hike in electricity tariffs for consumers on Band A feeders.
She said has said it before, and she is repeating, this banding of electricity is pure theft. Nowhere in the world is there Band A or whatever alphabet for electricity. Give everyone electricity and let them pay for what they consume.
